Brief: Abionyx Says Positive Clinical Results For CER-001 In Kidney Disease Associated With LCAT Deficiency

Abionyx Pharma SA

15/11/2021 06:49

Nov 15 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ANNOUNCES NEW POSITIVE CLINICAL RESULTS FOR CER-001 IN
KIDNEY
DISEASE ASSOCIATED WITH LCAT DEFICIENCY PUBLISHED IN JOURNAL OF
INTERNAL MEDICINE
    * WORSENING OF KIDNEY FUNCTION IN PATIENT WAS SLOWED BY
CER-001
INFUSIONS
    * KIDNEY BIOPSY SHOWED A REDUCTION OF LIPID DEPOSITS AND A
STABILIZATION OF DISEASE
    * RESULTS DEMONSTRATE THAT CER-001 HAS POTENTIAL TO BE
BENEFICIAL
IN OTHER RENAL DISEASES CHARACTERIZED BY RENAL LIPID DEPOSITS

Source text for Eikon:  ID:nBw2njxr7a 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))